Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis

Abstract

Treatment with pravastatin reduced the development of carotid atherosclerosis among patients with coronary heart disease and a wide range of pretreatment cholesterol levels. Treatment with this agent prevented any detectable increase in carotid wall thickening over 4 years of follow-up.